What Is Redosing?
Redosing means taking an additional amount of psilocybin after an initial dose, either during an active experience or shortly after one has ended. People attempt to redose for several reasons:
- The experience does not seem to have begun after 45–60 minutes.
- The experience feels less intense than expected and the person wants to deepen it.
- The experience is winding down and the person wants to extend it.
- They want to combine psilocybin sessions across multiple days.
In most of these scenarios, redosing is either ineffective, unpredictable, or both. Understanding the pharmacology explains why.
The Pharmacology of Tolerance: Why Redosing Doesn't Work
5-HT2A Receptor Downregulation
Psilocin — the active metabolite of psilocybin — produces its effects primarily by acting as a partial agonist at serotonin 5-HT2A receptors, particularly in the prefrontal cortex and default mode network. These receptors are the main site of psychedelic action.
When psilocin occupies 5-HT2A receptors, the brain responds defensively. Within 1–2 hours of exposure, the receptors begin to internalise: they are literally pulled off the cell surface and sequestered inside the neuron. This process — called receptor downregulation or desensitisation — reduces the number of functional 5-HT2A receptors available to respond to psilocin, even while psilocin remains in the bloodstream.
The result is a pharmacological ceiling: once the active experience is underway, additional psilocybin finds fewer and fewer receptors to activate. A second dose taken 1–2 hours into a session will find a significantly diminished receptor pool and produce a much weaker effect than the same dose taken at baseline.
Cross-Tolerance with Other Psychedelics
This receptor downregulation is not specific to psilocybin. It produces cross-tolerance with LSD, mescaline, DMT, and other classical serotonergic psychedelics. Taking any of these within 1–2 weeks of a psilocybin session will result in a noticeably blunted experience.
How Long Does Tolerance Last?
| Time after session | Approximate receptor availability | Expected effect of repeat dose |
|---|---|---|
| During session (hours 0–6) | Severely reduced | Minimal to none; may extend duration unpredictably |
| 24 hours | Still significantly reduced | Noticeably blunted — roughly 30–50% of baseline effect |
| 3–5 days | Partially recovered | Noticeably reduced effect |
| 7 days | Mostly recovered | Near-normal response for most people |
| 14 days | Fully reset | Full effect at baseline dose |
The "Delayed Onset" Problem: The Most Common Redosing Mistake
Psilocybin onset is highly variable. Depending on stomach contents, individual metabolism, preparation method, and starting anxiety level, onset can take anywhere from 20 minutes to 90 minutes. Many people misinterpret a slow onset as a failed dose.
The dangerous scenario unfolds like this:
- Person takes 2 g dried mushrooms. After 45 minutes: no noticeable effects.
- Assuming the dose was too low or the mushrooms were weak, they take another 1–2 g.
- At 60–75 minutes, both doses arrive simultaneously.
- The person experiences effects equivalent to 3–4 g, which they were not prepared for.
This is one of the most frequently reported causes of difficult or frightening experiences. The solution is always the same: wait at least 90–120 minutes before concluding a dose has not worked. Eating a light meal before taking mushrooms, or taking them in capsule form, can further slow absorption — but this does not mean the dose has failed.
When Might a Supplemental Dose Be Considered?
There is one specific, limited scenario where experienced users sometimes choose to take a small supplemental dose: at the 45–60 minute mark, if effects have clearly not yet begun and the initial dose was intentionally conservative (0.5–1 g). In this case, some users take an additional 0.5–1 g.
This is only appropriate under specific conditions:
- The initial dose was low (under 1.5 g dried equivalent).
- You are confident 60–90 minutes have genuinely passed with zero perceptible effects — not just reduced effects or subtle changes.
- A sober, experienced trip sitter is present.
- You are in a safe, comfortable environment with no commitments for the next 8 hours.
- You have previous experience with this substance and understand how your body responds.
- The supplemental dose is small — no more than half the initial dose.
This scenario does not apply to doses of 1.5 g or above, where slow onset should be expected and waited out rather than supplemented.
Between Sessions: How Long to Wait
Beyond the pharmacological tolerance question, there are psychological reasons to space sessions adequately apart. Integration — the process of making sense of and applying insights from a psychedelic experience — requires time and cognitive space. Rushing to the next session before the previous one has been processed reduces therapeutic or personal value and increases the risk of psychological difficulty.
| Dose type | Minimum spacing (pharmacological) | Recommended spacing (integration) |
|---|---|---|
| Microdose (0.05–0.3 g) | Every other day (Fadiman protocol) or every 3rd day | Off days are essential — tolerance-break days are built into all protocols |
| Threshold / museum dose (0.5–1.5 g) | 7 days | 2–4 weeks recommended |
| Moderate dose (1.5–3 g) | 7–14 days | 4–6 weeks |
| High dose (3.5 g+) | 14 days | 3–6 months or longer — high-dose experiences require extended integration |
Microdosing and Tolerance
Microdosing presents a different tolerance picture than macrodosing. At sub-perceptual doses (typically 0.05–0.15 g), 5-HT2A receptor downregulation does occur but is much less pronounced. Most established microdosing protocols incorporate mandatory off days to prevent tolerance accumulation:
- Fadiman Protocol: Dose on Day 1, off on Days 2–3, repeat. Provides recovery time between doses.
- Stamets Protocol: Dose on Days 1–4, off Days 5–7. Slightly higher tolerance risk but more popular among users seeking sustained cognitive effects.
- Every-other-day: Dose on Day 1, off Day 2, repeat. Conservative approach.
If you notice microdose effects fading despite adherence to a protocol, take a 2–4 week complete break before resuming. This is a sign of tolerance accumulation.
Key Principles for Dose Planning
- Set your dose before the session, not during it. Decisions made mid-experience are influenced by the experience itself and are not reliable.
- Weigh precisely. Eyeballed doses are inaccurate. Use a precision scale (0.01 g resolution for microdoses, 0.1 g for macrodoses).
- Account for set, setting, and stomach contents. An empty stomach, high anxiety, or an unfamiliar environment all accelerate and intensify onset. Factor these in before setting your dose.
- New batch = start low. Potency varies significantly between species, flushes, and growing conditions. Treat each new batch as unknown until you have assessed it at a low dose.
- Write down your dose and time before consuming. You will not remember these accurately mid-experience.
- Do not redose to rescue a difficult experience. If the experience is overwhelming, no additional dose will help. Use grounding techniques, call your sitter, and if necessary use a benzodiazepine to reduce intensity.
Related Guides
How psilocybin is absorbed, metabolised, and cleared.
Dosage PreparationHow to weigh and prepare accurate doses.
Difficult Experience GuideWhat to do if an experience becomes overwhelming.
Microdosing ProtocolsFadiman, Stamets, and other established microdosing schedules.
Frequently Asked Questions
I took 2 g an hour ago and feel nothing. Should I take more?
Wait. Onset can take up to 90 minutes on a full stomach or with certain preparation methods. Sit quietly, breathe, and observe your state carefully. Very early effects — subtle warmth, slight visual brightening, mild shifts in sound — can easily be missed if you are anxious or distracted. If 90–120 minutes pass with absolutely no perceptible shift, a small supplemental dose (0.5–1 g) may be considered, but only if you are in a safe environment with a sober sitter present.
Can I take a booster dose 3 hours into a session to extend it?
At hour 3 of a psilocybin session, 5-HT2A receptors are significantly downregulated. An additional dose is unlikely to meaningfully extend or intensify the experience and may only prolong the afterglow and delay sleep. The session will resolve on its own schedule. Accept and work with what the experience presents rather than trying to control its duration.
Why does psilocybin tolerance develop faster than cannabis or alcohol tolerance?
Cannabis and alcohol produce tolerance through a combination of metabolic adaptation (the liver enzymes that break them down become more efficient) and receptor desensitisation. Psilocybin tolerance is almost entirely receptor-level: 5-HT2A receptors internalise rapidly in response to agonist occupancy. This mechanism is extremely fast — it begins within the first hour of psilocin binding — which is why even within a single session, the experience naturally plateaus regardless of plasma psilocin levels.
Does tolerance affect psilocybin's antidepressant effects?
Current clinical research protocols typically space therapeutic psilocybin sessions 1–4 weeks apart. Therapeutic effects appear to persist well beyond the pharmacological tolerance window, likely because they are mediated by neuroplasticity changes (BDNF upregulation, synaptic remodelling) rather than ongoing receptor occupation. Weekly sessions are not more effective than properly spaced sessions and carry higher psychological burden.
Is there a way to reduce tolerance to make redosing more effective?
No practical method exists for rapidly reversing intra-session tolerance. Time is the only solution — receptor recycling back to the cell surface takes days. Some anecdotal reports suggest that very high-dose vitamin C (ascorbic acid) may modestly reduce tolerance, but there is no scientific evidence supporting this. Planning the correct initial dose remains the only reliable strategy.